| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000005758 |
| Receipt No. | R000006688 |
| Scientific Title | Prospective study of pancreatic exocrine function after pancreaticoduodenectomy |
| Date of disclosure of the study information | 2011/06/15 |
| Last modified on | 2019/04/17 (Ver. 3) |
| Basic information | ||
| Public title | Prospective study of pancreatic exocrine function after pancreaticoduodenectomy | |
| Acronym | Prospective study of pancreatic exocrine function after pancreaticoduodenectomy | |
| Scientific Title | Prospective study of pancreatic exocrine function after pancreaticoduodenectomy | |
| Scientific Title:Acronym | Prospective study of pancreatic exocrine function after pancreaticoduodenectomy | |
| Region |
|
|
| Condition | |||
| Condition | Periampullary tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the difference of pancreatico-enteric anastomosis in long-term pancreatic exocrine function after pancreaticoduodenectomy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The Incidence of pancreatic exocrine inefficiency one year after surgery |
| Key secondary outcomes | The Incidence of pancreatic exocrine inefficiency three months and two year after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Duct-to-mucosa pancreatico-gastrostomy for pancreatico-enterostomy | |
| Interventions/Control_2 | Duct-to-mucosa pancreatico-jejunosotmy for pancreatico-enterostomy | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | On the diagnosis of periampullary malignancy, benign tumor or inflammatory disease, the patient is going to undergo pancreaticoduodenectomy with duodeno-jejunostomy | |||
| Key exclusion criteria | 1.Patients with acute ischemic heart disease
2.Patients with liver cirrhosis or active hepatitis 3. Patients with interstitial pneumonia or fibroid lung who require oxygen administration 4. Patients with chronic renal failure requiring dialysis 5. Patients with other malignant disease 6. Patients who require concomitant resection of other organ 7. Patients who are diagnosed to be ineligible by the investigator. |
|||
| Target sample size | 74 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Hiroshima University Hospital | ||||||
| Division name | Gastrointestinal Surgery | ||||||
| Zip code | |||||||
| Address | 1-2-3Kasumi, Minamiku, Hiroshima | ||||||
| TEL | 082-257-5216 | ||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Hiroshima University Hospital | ||||||
| Division name | Gastrointestinal Surgery | ||||||
| Zip code | |||||||
| Address | 1-2-3Kasumi, Minamiku, Hiroshima | ||||||
| TEL | 082-257-5216 | ||||||
| Homepage URL | |||||||
| Sponsor | |
| Institute | Hiroshima University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Wakayama Medical University |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県)、和歌山県立医科大学病院(和歌山県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006688 |